Evidence map›Paper›PMID 32325887›Full record

ArticleJournal of clinical medicine2020

Observed and Expected Survival in Men and Women After Suffering a STEMI.

Isaac Pascual, Daniel Hernandez-Vaquero, Marcel Almendarez, Rebeca Lorca, Alain Escalera, Rocío Díaz, Alberto Alperi, Manuel Carnero, Jacobo Silva, Cesar Morís and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 30 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Isaac PascualDepartment of Cardiology. Central University Hospital of Asturias, 33011 Oviedo, Spain.
Daniel Hernandez-VaqueroResearch Institute of the Principado de Asturias, Oviedo, 33011, Spain.
Marcel AlmendarezDepartment of Cardiology. Central University Hospital of Asturias, 33011 Oviedo, Spain.
Rebeca LorcaDepartment of Cardiology. Central University Hospital of Asturias, 33011 Oviedo, Spain.
Alain EscaleraCardiac Surgery Department. Central University Hospital of Asturias, 33011 Oviedo, Spain.
Rocío DíazResearch Institute of the Principado de Asturias, Oviedo, 33011, Spain.
Alberto AlperiDepartment of Cardiology. Central University Hospital of Asturias, 33011 Oviedo, Spain.
Manuel CarneroCardiac Surgery Department. San Carlos Clinic Hospital. 28040 Madrid, Spain.
Jacobo SilvaCardiac Surgery Department. Central University Hospital of Asturias, 33011 Oviedo, Spain.
Cesar MorísDepartment of Cardiology. Central University Hospital of Asturias, 33011 Oviedo, Spain.
Pablo AvanzasDepartment of Cardiology. Central University Hospital of Asturias, 33011 Oviedo, Spain.
Universidad de Oviedo · ESHospital Universitario Central de Asturias · ESGobierno del Principado de Asturias · ESHospital Clínico San Carlos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMortality caused by ST elevation myocardial infarction (STEMI) has declined because of greater use of primary percutaneous coronary intervention (PCI). It is unknown if patients >75 have similar survival as peers. We aim to know it stratifying by sex and assessing how the sex may impact the survival.

methodsWe retrospectively selected all patients >75 who suffered a STEMI treated with primary PCI at our institution. We compared their survival with that of the reference population (general population matched by age, sex, and geographical region). A Cox-regression analysis controlling for clinical factors was performed to know if sex was a risk factor.

resultsTotal of 450 patients were studied. Survival at 1, 3, and 5 years of follow-up for patients who survived the first 30 days was 91.22% (CI95% 87.80-93.72), 79.71% (CI95% 74.58-83.92), and 68.02% (CI95% 60.66-74.3), whereas in the reference population it was 93.11%, 79.10%, and 65.01%, respectively. Sex was not a risk factor, Hazard Ratio = 1.02 (CI95% 0.67-1.53;

conclusionsLife expectancy of patients suffering a STEMI is nowadays intimately linked to survival in the first 30 days. After one year, the risk of death for both men and women seems similar to that of the general population.

Indexed as

genderlife expectancymyocardial infarction

Identifiers

PMID32325887
PMCPMC7230566
OpenAlexW3016833140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.